SOURCE: Gilead Sciences
DESCRIPTION:
In a year defined by chaos, teams across Gilead raced against time and pushed through obstacles to help advance a potential treatment to patients early in the COVID-19 pandemic.
In the first episode of our new “Possible” documentary series, learn how Anu Osinusi, an infectious disease physician who leads the company’s Emerging and Respiratory Viruses group, worked with colleagues across the company, regulatory authorities and external partners to get an investigational antiviral treatment to a patient in Seattle. In the process, the Gilead teams demonstrated how employees create possible.
Watch other episodes of our “Possible” series here.
KEYWORDS: NYSE:GILD, Gilead Sciences
